thiotepa - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
TEPADINA thiotepa 100 mg powder for injection vial AUST R: 370353Active ingredients:
thiotepa
Dosage form: Injection, powder for
Sponsor: Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Phone: 02 8401 9777
|
From 03 May 2024 to 01 Apr 2025
|
Shortage status: Current
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: An alternative generic product is available.
|
TEPADINA thiotepa 15 mg powder for injection vial AUST R: 370352Active ingredients:
thiotepa
Dosage form: Injection, powder for
Sponsor: Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Phone: 02 8401 9777
|
From 30 Oct 2024 to 01 Apr 2025
|
Shortage status: Current
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
|
TEPADINA thiotepa 400 mg powder for injection and solvent dual chamber infusion bag AUST R: 370354Active ingredients:
thiotepa
Dosage form: Injection, powder for
Sponsor: Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Phone: 0284019777
|
From 08 Jan 2024 to 01 Apr 2025
|
Shortage status: Current
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Alternative products in other strengths are available.
|
THIOTEPA-REACH thiotepa 15 mg powder for injection vial AUST R: 364527Active ingredients:
thiotepa
Dosage form: Injection, powder for
Sponsor: Reach Pharmaceuticals Pty Ltd
Phone: 0422429648
|
From 09 Dec 2024 to 27 Dec 2024
|
Shortage status: Current
Availability: Limited Availability
Reason: Unexpected increase in consumer demand
Management action: The sponsor is working to expedite the next shipment. If Australian registered stock is unavailable, an alternative product may be available via the Special Access Scheme (SAS)
|